Azmi Nabulsi, M.D., M.P.H., has been named president, Takeda Global R&D Center, Inc., U.S. Dr. Nabulsi will report to Nancy Joseph-Ridge, M.D., general manager, pharmaceutical development division, Takeda Pharmaceuticals International. He will direct all aspects of Takeda’s U.S. drug development activities, including the identification of new product candidates, execution of clinical trial programs and support for new lifecycle management approaches for the company’s marketed products.

Dr. Nabulsi brings more than 20 years of experience to his new position. Previously he was general manager for Takeda’s Strategic Development Department based in Osaka, Japan, where he was responsible for overseeing the company’s global portfolio strategies, development plans, and performance and productivity initiatives. Prior to that, he held roles within R&D operations for Takeda Global R&D Center. Dr. Nabulsi joined Takeda in 2004 after a 10-year career at Abbott, where he held multiple global leadership positions in the development division.